EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-243.43M
↓ 216% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-77.10M
Historical baseline
PeriodValueYoY Change
2025$-243.43M-66.9%
2024$-145.85M-94.3%
2023$-75.07M+24.7%
2022$-99.64M-80.3%
2021$-55.28M-48.2%
2020$-37.29M+22.1%
2019$-47.86M-82.2%
2018$-26.27M-41.4%
2017$-18.58M+14.7%
2016$-21.77M-